Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial.

Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial.

Item

http://www.wikidata.org/entity/Q34694463

Q34694463

about

Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial Cerebral Palsy-Trends in Epidemiology and Recent Development in Prenatal Mechanisms of Disease, Treatment, and Prevention Transabdominal evaluation of uterine cervical length during pregnancy fails to identify a substantial number of women with a short cervix.Vaginal progesterone, but not 17α-hydroxyprogesterone caproate, has antiinflammatory effects at the murine maternal-fetal interface.17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length.Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysis Patients with an asymptomatic short cervix (<or=15 mm) have a high rate of subclinical intraamniotic inflammation: implications for patient counseling 17-Hydroxyprogesterone caproate to prolong pregnancy after preterm rupture of the membranes: early termination of a double-blind, randomized clinical trial.Clinical significance of early (< 20 weeks) vs. late (20-24 weeks) detection of sonographic short cervix in asymptomatic women in the mid-trimester.Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data Cervical tissue engineering using silk scaffolds and human cervical cells Cervical strain determined by ultrasound elastography and its association with spontaneous preterm delivery Second trimester cervical length and risk of preterm birth in women with twin gestations treated with 17-α hydroxyprogesterone caproate Maternal characteristics influencing the development of gestational diabetes in obese women receiving 17-alpha-hydroxyprogesterone caproate.Pharmacologic actions of progestins to inhibit cervical ripening and prevent delivery depend on their properties, the route of administration, and the vehicle.Progesterone withdrawal promotes remodeling processes in the nonpregnant mouse cervix A novel optical method to assess cervical changes during pregnancy and use to evaluate the effects of progestins on term and preterm labor.Progestin treatment for the prevention of preterm birth.Guidelines for the management of spontaneous preterm labor: identification of spontaneous preterm labor, diagnosis of preterm premature rupture of membranes, and preventive tools for preterm birth Maternal Whole Blood Gene Expression at 18 and 28 Weeks of Gestation Associated with Spontaneous Preterm Birth in Asymptomatic Women.Evaluation of two treatment strategies for the prevention of preterm birth in women identified as at risk by ultrasound (PESAPRO Trial): study protocol for a randomized controlled trial.Beyond Cervical Length: A Pilot Study of Ultrasonic Attenuation for Early Detection of Preterm Birth Risk Comparative Study of Vaginal versus Intramuscular Progesterone in the Prevention of Preterm Delivery: A Randomized Clinical Trial Assessment of DHA on reducing early preterm birth: the ADORE randomized controlled trial protocol.Vaginal progesterone in risk reduction of preterm birth in women with short cervix in the midtrimester of pregnancy Medroxyprogesterone acetate modulates remodeling, immune cell census, and nerve fibers in the cervix of a mouse model for inflammation-induced preterm birth Is sonographic assessment of the cervix necessary and helpful?Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis Comparison of the mechanisms responsible for cervical remodeling in preterm and term labor.The risk of impending preterm delivery in asymptomatic patients with a nonmeasurable cervical length in the second trimester.Estrogen and progesterone metabolism in the cervix during pregnancy and parturition Vaginal progesterone on the prevention of preterm birth and neonatal complications in high risk women: A randomized placebo-controlled double-blind study.Preterm Birth Prevention: Effects of Vaginal Progesterone Administration on Blood Flow Impedance in Uterine-Fetal Circulation by Doppler Sonography.The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies Vaginal progesterone to reduce the rate of preterm birth and neonatal morbidity: a solution at last.Progesterone to prevent preterm birth in twin gestations: what is the next step forward?Progesterone supplementation for HIV-positive pregnant women on protease inhibitor-based antiretroviral regimens (the ProSPAR study): a study protocol for a pilot randomized controlled trial Actions of progestins for the inhibition of cervical ripening and uterine contractions to prevent preterm birth.Cerclage for the prevention of preterm birth in high risk women receiving intramuscular 17-α-hydroxyprogesterone caproate.The role of progesterone in maternal and fetal medicine.

P2860

Q24622553-974F5E83-AD7A-4643-BB8A-68DA39641928 Q30235534-02FCB9EE-6E0A-40C6-9814-EA72F983B347 Q30464228-74F8055B-B61F-4515-92BD-92DA4597E09F Q30702434-6F1078DE-F858-42D1-8CAF-76E58EC713C0 Q33794307-473FA13C-7EB5-4C20-BDCE-1AFE4FCA40A0 Q33886845-F254BAF9-20C5-4D9D-8074-B32391E700EF Q34080320-66D136F1-690B-4580-84F7-3E4D4095B344 Q34113982-219975EC-956A-4BF1-8A1A-9A121B68AB32 Q34118250-7A8932A8-A4F8-427F-90A5-DE3A29984C57 Q34143212-3CBD26DB-F8A3-4FC2-879A-A401C8599157 Q34171382-20149258-F9DB-4575-8F37-916FE80EE3B0 Q34281817-B996441F-CE1B-43B2-8787-BF82E722175A Q34392086-FE371C14-A1BF-4F1F-B3E4-444B8E3EC642 Q34487386-C748C635-5320-4536-83BE-08A674B98036 Q34620970-BF88275F-E475-4B25-A5D7-F3BAA2DDC330 Q34979402-7E3F9407-13EB-400D-B757-CAC57A72FE12 Q35156867-BD9B7877-A2A7-4902-85F4-036FA0188434 Q35223822-3EC89960-F69F-42A4-ADDA-294D668A40F8 Q35703067-FA921940-D5BC-45E0-BE9C-B8F630956907 Q36059037-7B32391A-89A3-47CF-A6EA-5D666DC133ED Q36095536-E28A8DB7-F8D1-41E8-B1F9-B881FB2210A0 Q36122450-C4002405-FC7E-4FB3-91FB-F4D46C8F9419 Q36217310-AC818B50-4BF6-4CE0-89B6-2E015B0DCA44 Q36279075-51D44C22-5B15-44A0-9FC0-9EF75F7ADB93 Q36311625-FEE30A28-D3BC-4280-BA93-6BEBB8DBF783 Q36328567-4606BB01-F100-4910-8F6A-80DCCF991536 Q36464938-9846D12F-6D74-42C1-95E6-62FF1FAF45FA Q36487287-F3CB498D-3C93-44B0-8ADF-F2CF6A38C4C1 Q36636728-8719BE13-D48B-4C3A-B409-837BB4FE26AC Q36692485-5B4B7282-999B-4960-A1C5-1947EB06EBC8 Q36732634-D4D4EE9C-FD27-4861-9AA9-C6DE0FE0B0D6 Q37010395-AEEC1D59-F9BD-4FEB-8ACF-2E4506D48EAF Q37137051-802EE7D6-3258-4AB4-84E2-A2A11DA0A87A Q37381190-EDC73FF3-45DC-4EED-953B-5D20BF2B8DEE Q37486770-1189291D-ECD6-49E7-B426-23ABA5CB4CEB Q37487072-6C53963E-CC8B-4466-97D1-46D586563565 Q37498149-C4E624A0-2D7E-4FD8-994C-431F40EC1AA1 Q37704144-2ECF83E3-48C8-44B4-BCF6-AD4EF5471323 Q37709667-ED90018E-E9B5-4D25-8F5B-4CCD9DB83C1F Q38051406-DF772320-4C37-4AD9-9EA9-0521212C5170

P2860

Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial.

Item

http://www.wikidata.org/entity/Q34694463

description

2007 nî lūn-bûn

@nan

2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu